Otsuka Holdings (4578) Stock Price, Fundamentals & Analysis

What 4578 does

Otsuka Holdings (4578) is a diversified healthcare company listed on the Tokyo Stock Exchange stocks. It develops and sells pharmaceutical products in areas such as psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune and digestive system disorders, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. Beyond core pharmaceuticals, the company operates in nutraceuticals, consumer products, and other businesses, including clinical testing, food products, cosmetics, functional food products, and IT solutions.

Key numbers explained

• 11,160 JPY is the current price for one share of Otsuka Holdings (4578).
• The trailing P/E ratio of 14.5 shows how much investors pay per unit of the company's last 12 months' earnings; a lower figure can suggest a more modest valuation relative to recent earnings.
• The forward P/E ratio of 21.5 uses expected future earnings, giving a sense of how the market prices in growth.
• 767.81 JPY is the earnings per share over the trailing 12 months, representing the portion of profit attributable to each share.
• The dividend yield of 1.79% indicates the annual dividend payment as a percentage of the current share price.
• 22% is the share of earnings paid out as dividends, showing how much of the company's profit is returned to shareholders.
• -0.05 is the beta, meaning the stock's price movements have historically been slightly less volatile than the broader market.
• 17.4% is the year-over-year revenue growth, showing how quickly the company's top line has expanded recently.

What to watch

• Earnings reports and guidance updates, such as the upcoming report on 30 oct. 2026, can move the stock as they reveal changes in sales, margins, and outlook.
• The healthcare sector's regulatory environment, including drug approvals and patent expirations, can affect Otsuka Holdings (4578) and its peers like Astellas (4503), Chugai Pharmaceutical (4519), and Eisai (4523).
• Broader market indices, such as the Nikkei 225, can influence the stock's price as part of the Japanese equity market.
• Currency movements and geopolitical factors that affect global pharmaceutical demand and supply chains are relevant for a company with international operations.